Cleared Traditional

EndoLIF Delta-Cage and DoubleWedge-Cage (K203014) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K203014 · Joimax GmbH · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2021
Decision
335d
Days
Class 2
Risk

K203014 is an FDA 510(k) clearance for the EndoLIF Delta-Cage and DoubleWedge-Cage. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Joimax GmbH (Raumfabrik 61, DE). The FDA issued a Cleared decision on September 1, 2021 after a review of 335 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Joimax GmbH devices

Submission Details

510(k) Number K203014 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 2020
Decision Date September 01, 2021
Days to Decision 335 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
213d slower than avg
Panel avg: 122d · This submission: 335d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Gary Mocnik and Associates
Gary Mocnik

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 464
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K203014.
KEYSTONE PEEK Cage System
K211689 · Shanghai Sanyou Medical Co, Ltd. · Sep 2021
Kleiner KG2 System
K211474 · BAAT Medical Products B.V. · Sep 2021
Explorer TO System
K212540 · SeaSpine Orthopedics Corporation · Sep 2021
Impulse AM Interbody Fusion System
K210090 · Degen Medical · Aug 2021
KMTI S141 Lumbar Interbody Fusion System
K212070 · Kyocera Medical Technologies, Inc. · Aug 2021
BEE PLIF Cage
K211413 · NGMedical GmbH · Aug 2021